Linkedin Facebook Instagram X-twitter
Main Menu
PRESENTATION
PARTNER WITH US
MENU
Main Menu
PRESENTATION
SUBSCRIBE
Linkedin Facebook Instagram X-twitter

Practical AI Platform

for Disease Risk Stratification.

Predict. Prevent. Transform.

ALZAI transforms routine healthcare data
into disease-specific risk insights,
helping identify high-risk populations earlier
and enabling more targeted clinical action.

Explore Our Platform →
THE ALZAI PLATFORM

Turning Routine Healthcare Data Into Disease-Specific Risk Insights

ALZAI’s platform analyzes existing clinical data, applies proprietary AI models, stratifies risk across patient populations and delivers actionable outputs into healthcare workflows.
Use Existing Health Data · Database
Routine
Healthcare Data
Routine Healthcare Data
EMR Data Lab Results
Clinical History
Demographics
ALZAI_ICON_COL@4x
ALZAI
AI Platform
Proprietary AI models
Population Risk Stratification · People
Disease-Specific
Risk Stratification
Identify elevated risk across populations
Actionable Outputs · Document
Actionable
Outputs
Support earlier, more targeted action
DISEASE AREAS

A Growing Portfolio of Disease-Specific Risk Models

Validated models in brain health and liver health, with additional disease areas in development.
BRAIN HEALTH
Alzheimer’s
Disease

AlzAI for Alzheimer’s Disease risk stratification.
Explore AlzAI →
LIVER HEALTH
Liver’s
Disease

LivAI for Liver Disease risk stratification
Explore LivAI →
EXPANDING PORTFOLIO
More Disease
Models in Development
Scalable AI architecture for chronic diseases.
View Our Pipeline →
MARKETS

One Platform. Multiple Healthcare Markets.

Our technology supports a wide range of stakeholders across the healthcare ecosystem.
Healthcare Providers
Turn existing healthcare
data into predictive insights
within clinical workflows.

For Health Systems →
Health Plans
Support earlier
identification, care optimization and
risk-adjustment workflows.
Health Plans →
Clinical Trials
Identify the right patients
earlier and accelerate
recruitment.

For Clinical Trials →
Pharma
Identify treatment-eligible
populations throughout
drug lifecycles.

 

For Pharma →
Longevity
Bring disease-risk insights
into preventive and
personalized health
programs.
For Longevity →
NEWS & UPDATES 

Stay Up to Date with ALZAI Health

Explore our latest company news, strategic partnerships, research milestones and corporate developments.
ALZAI Health Corp. Posted for Trading On The OTCQB Venture Market
Read More →
ALZAI Health Corp. Posted for Trading On The Frankfurt Stock Exchange
Read More →
ALZAI Health Corp. Announces Marketing Services Agreement
Read More →
ALZAI and Linus Health explore AI-driven collaborations aimed at early identification of Alzheimer’s disease risk and cognitive impairment
Read More →
View More News